Healthequity (HQY) Non-Current Deferred Tax Liability (2014 - 2026)

Healthequity's Non-Current Deferred Tax Liability history runs 13 years deep, the most recent figure standing at $95.4 million for Q2 2026.

• On a quarterly basis, Non-Current Deferred Tax Liability rose 66.82% year-over-year to $95.4 million in Q2 2026; TTM through Apr 2026 was $95.4 million, a 66.82% increase from a year earlier, with the FY2026 full-year figure at $93.7 million, up 67.84% from the prior year.
• Non-Current Deferred Tax Liability advanced to $95.4 million in Q2 2026 per HQY's latest filing, from $93.7 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $160.8 million in Q1 2022 and bottomed at $55.8 million in Q1 2025.
• The 5-year median for Non-Current Deferred Tax Liability is $87.9 million (2022), against an average of $90.3 million.
• Biggest YoY gain for Non-Current Deferred Tax Liability was 73.32% in 2025; the steepest drop was 60.51% in 2025.
• Year by year, Non-Current Deferred Tax Liability stood at $89.3 million in 2022, then fell by 25.25% to $66.7 million in 2023, then slipped by 12.19% to $58.6 million in 2024, then soared by 73.32% to $101.6 million in 2025, then fell by 6.12% to $95.4 million in 2026.
• Per Business Quant, the three latest HQY Non-Current Deferred Tax Liability figures stand at $95.4 million (Q2 2026), $93.7 million (Q1 2026), and $101.6 million (Q4 2025).